Meloni Marco, Uccioli Luigi, Andreadi Aikaterini, Giurato Laura, Ruotolo Valeria, Romano Maria, Minasi Alessandro, Bellizzi Ermanno, Bonanni Federico Rolando, Salvi Martina, Bellia Alfonso, Lauro Davide
Department of Systems of Medicine, University of Tor Vergata, Rome, 00133, Italy.
Division of Endocrinology and Diabetology, Department of Medical Sciences, University Hospital Fondazione Policlinico Tor Vergata, Rome, Italy.
Acta Diabetol. 2025 Sep 4. doi: 10.1007/s00592-025-02577-1.
The study aimed to evaluate the rate and causes of major amputation in patients with diabetic foot syndrome.
The current study is a retrospective observational study including consecutive patients referred to a tertiary-level diabetic foot service from January 2020 to November 2023 due to a new diabetic foot problem requiring hospital admission. All patients had been managed by a multi-disciplinary diabetic foot team (MDFT) through a pre-set limb salvage protocol including the management of peripheral arterial disease, infection, foot offloading, and comorbidities. At 1 year of follow-up, the following outcomes measures were evaluated: rate of major amputation, clinical characteristics of amputees, and causes of major amputation.
Overall, 1226 patients referring for a diabetic foot problem and requiring hospitalization were screened for the study. Among them, 30 (2.4%) patients experienced major amputation. Amputees had 69.9±10.7 years, the majority were male (73.3%) with a prevalence of type 2 diabetes (93.3%) and a long diabetes duration (25.2±9.8 years). They showed several comorbidities such as ischaemic heart disease (83.3%), heart failure (46.7%), end-stage-renal-disease (26.7%), and in addition high rate of peripheral arterial disease (PAD) (86.7%), infected wounds (98.3%), and osteomyelitis (90%). Major amputation was mainly related to untreatable limb ischemia (failure of revascularization procedure) in 56.7% of cases, calcaneus osteomyelitis and necrotizing fasciitis in 16.7% of cases, and tarsal osteomyelitis in 10% of cases.
The rate of major amputation was very low in this population managed by a MDFT. PAD was the main cause of major amputation.
本研究旨在评估糖尿病足综合征患者大截肢的发生率及原因。
本研究为回顾性观察性研究,纳入了2020年1月至2023年11月因新发糖尿病足问题需住院治疗而转诊至三级糖尿病足诊疗中心的连续患者。所有患者均由多学科糖尿病足团队(MDFT)通过预设的保肢方案进行管理,该方案包括外周动脉疾病、感染、足部减压及合并症的管理。在随访1年时,评估以下结局指标:大截肢发生率、截肢患者的临床特征及大截肢原因。
总体而言,1226例因糖尿病足问题就诊并需住院治疗的患者被纳入本研究筛查。其中,30例(2.4%)患者接受了大截肢。截肢患者年龄为69.9±10.7岁,大多数为男性(73.3%),2型糖尿病患病率为93.3%,糖尿病病程较长(25.2±9.8年)。他们存在多种合并症,如缺血性心脏病(83.3%)、心力衰竭(46.7%)、终末期肾病(26.7%),此外外周动脉疾病(PAD)发生率高(86.7%)、伤口感染(98.3%)和骨髓炎(90%)。大截肢主要与56.7%的病例中不可治疗的肢体缺血(血管重建手术失败)、16.7%的病例中跟骨骨髓炎和坏死性筋膜炎以及10%的病例中跗骨骨髓炎有关。
在由MDFT管理的这一人群中,大截肢发生率非常低。PAD是大截肢的主要原因。